Search Results

Inimmune Corporation announced that it has entered a research collaboration with Boston Children’s Hospital to develop novel and innovative small molecule vaccine adjuvants.

Senzime AB announced that it has secured a purchasing contract with the number one ranked children’s hospital system in the United States for its TetraGraph® quantitative neuromuscular monitoring system.

Researchers from Children’s Hospital of Philadelphia found that young children between the ages of 5 and 12 were more likely to experience a concussion from recreation and other non-sport activities, yet those injuries were not seen by specialists until days later compared with sports-related concussions in the same age group.

Eureka Therapeutics, Inc. today announced the activation of UCSF Benioff Children’s Hospitals as the first California site to join the ARYA-2 clinical trial ( NCT04634357 ).

Boston Pharma’s once-monthly injection efimosfermin alfa offers a convenient dosing option for MASH patients while also achieving promising rates of fibrosis and MASH improvement, according to a Phase II readout.

In a landmark study, researchers from Children’s Hospital of Philadelphia found that two separate objective assessment tools and nonverbal measurements of IQ can help assess cognitive function in children with Aicardi Goutières Syndrome, allowing treatment teams to provide appropriate support and interventions.

Inozyme Pharma, Inc. announced a data presentation and sponsored symposium at the 11th International Conference on Children’s Bone Health, which is being held June 22-25, 2024, in Salzburg, Austria.

Children’s Hospital of Philadelphia announced it has entered into a Memorandum of Understanding with Sidra Medicine, a specialty healthcare organization for women, children and young people in Qatar.